TRENTON, N.J. — So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it?
You are here
By Linda A. Johnson The Associated Press
TRENTON, N.J. — First it was the leader of a major U.S. pharmaceutical, then the CEO of an athletic gear company, and before the day had ended, the chief executive of a $170 billion tech giant. Three of the nation’s top executives resigned from a federal panel created years ago to advise the U.S. president.
The maker of opioid painkiller Opana ER is pulling the drug off the market at the request of federal regulators because it’s being abused.
U.S. health agencies on Wednesday warned that certain blood tests for lead poisoning may give results lower than the actual level of lead.
As a result, some children under 6, along with pregnant and nursing women, may need retesting, the Food and Drug Administration and Centers for Disease Control and Prevention said.
TRENTON, N.J. — The Food and Drug Administration on Wednesday again warned patients and doctors to avoid a risky, experimental procedure promoted as a treatment for several nervous system disorders, including multiple sclerosis and Parkinson’s disease.
The procedure involves inflating a tiny balloon in narrowed veins, usually in the neck, to widen them and improve blood flow.
TRENTON, N.J. — Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.
The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland ‚Äî at least on paper ‚Äî to reduce its tax bill.